Chiron Files Pulminiq NDA As Feds Probe Flu Vaccine Miscue Oct. 15, 2004 By Aaron Lorenzo Releasing a bit of good news, Chiron Corp. submitted a new drug application for Pulminiq inhalation solution for lung transplant patients. (BioWorld Today)Read More
AtheroGenics Drops AGIX-4207 After Phase II Miss In Arthritis Oct. 14, 2004 By Aaron Lorenzo AtheroGenics Inc. is discontinuing the development of one of its investigational drugs following a Phase II failure. (BioWorld Today)Read More
RSS